Physician profile
Robert Allen
NPI 1952376949
$4,658.10
in general payments reported to CMS, 2019-2025
26 companies · $548 in 2025
The $548 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $1,506 · 2021: $883 · 2022: $534 · 2023: $195 · 2024: $513 · 2025: $548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,256.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,810.65 | 2019-2025 | Proclaim, Eterna |
| Nevro Corp. | $845.88 | 2019-2024 | Senza |
| Globus Medical, INC. | $346.86 | 2025 | Senza, Excelsius Gps |
| Zap Surgical Systems, INC. | $250.71 | 2020 | |
| Providence Medical Technology, INC. | $239.71 | 2022-2024 | |
| Medtronic, INC. | $181.47 | 2024-2025 | Kyphon Express II Kyphopak Tray, Aquamantys(Tm), Plasmablade(Tm) |
| Siemens Medical Solutions USA, INC. | $146.94 | 2022 | |
| Medtronic USA, INC. | $122.13 | 2019-2020 | |
| Boston Scientific Corporation | $105.57 | 2023-2025 | Wavewriter Alpha Prime 16 |
| Arbor Pharmaceuticals, INC. | $100.00 | 2022 | |
| Brainlab, INC. | $100.00 | 2019 | |
| Stryker Corporation | $55.14 | 2025 | N/A |
| Pacira Pharmaceuticals Incorporated | $50.49 | 2019 | |
| Ibsa Pharma INC. | $41.67 | 2025 | Flector, Licart, Tirosint |
| Depuy Synthes Sales INC. | $36.84 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $35.06 | 2023-2025 | Spinal-Stim, Spinal-Stim |
| Sonex Health, INC. | $32.52 | 2023 | Sx-One Microknife |
| Becton, Dickinson and Company | $31.39 | 2024 | |
| Nalu Medical, INC. | $21.01 | 2022 | |
| Baxter Healthcare | $20.18 | 2021 | |
| Microvention, INC. | $19.94 | 2020 | |
| Penumbra, INC. | $19.48 | 2024 | Penumbra System |
| Collegium Pharmaceutical, INC. | $16.18 | 2023 | Xtampza |
| Astrazeneca Pharmaceuticals Lp | $14.62 | 2022 | |
| Cerapedics INC. | $13.66 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.